The principle scientific liaison from the United States Pharmacopeia (USP) will clarify details regarding the first compendial general chapter, USP <665>, detailing a standard assessment and testing approach for qualification of plastic components and systems used in drug manufacturing. This discussion will focus on the shift to this new approach and the necessity to conduct previous compendial test methods.
The expert panel will examine USP <665> in relation to other plastic qualification approaches. This discussion will include details regarding shifting away from USP <661>, along with questioning the necessity of other related general chapter methods. Specifically, USP <661.1> and <661.2> will be highlighted, which are typically utilized for material characterization and drug packaging component characterization, respectively. In the end, you will be more confident in understanding what, how, and when best to utilize the new compendial USP <665> standard extractables test methods.
In this webinar, you will:
- Understand details regarding the first official compendial general chapter, USP <665> for plastic components and systems used in drug manufacturing
- Learn about the scope and justification to help you eliminate the need for previous testing methods which are no longer directly relevant
- Leverage expert knowledge and regulatory support to plan the best approach to transition to this new USP <665> compendial extractables testing standard
Speakers
Janmeet Anant, Ph.D.
Merck
Senior Regulatory Consultant
Janmeet Anant has been providing regulatory consulting for biopharmaceutical manufacturers for more than 10 years. Janmeet has a global Regulatory Affairs Certification (RAC), a B.S. in Chemistry, and a Ph.D. in Pharmacology.
Monica Cardona
Merck
Senior Program Manager
Monica Cardona is a senior program manager for single-use and integrated systems at Merck. She has worked in life sciences for more than 20 years. She has had several global roles in technical, strategic, and operational marketing.
Monica holds a B.S. in Biology from Hofstra University and an M.S in Biology from Adelphi University. She has published and lectured internationally on a wide range of filtration, validation, and single-use bioprocessing topics. Monica is a member of the Parenteral Drug Association (PDA), BioPhorum, and a founding member of Bio-Process Systems Alliance (BPSA).
Desmond Hunt, Ph.D.
United States Pharmacopeia (USP)
Principle Scientific Liaison
Desmond G. Hunt, Ph.D. is the scientific liaison to the Packaging and Distribution and Dosage Forms Expert Committees, where he works to develop and revise standards at the United States Pharmacopeia (USP).
He has authored many publications, is a frequent speaker and instructor on topics related to pharmaceutical packaging, particulate matter in parenteral and ophthalmic dosage forms and good storage and transportation practices. He also participates on industry Working Groups and Technical Committees. Desmond obtained his M.S. and Ph.D. from the University of Texas at Austin.
Pharma and biopharma manufacturing
- Compendial Testing and Regulatory Guidance
Dauer:1h
Sprache:English
Sitzung 1:vorgestellt February 17, 2022
Um weiterzulesen, melden Sie sich bitte an oder erstellen ein Konto.
Sie haben kein Konto?